[1] Cai, Y.Z.; Sun, M.; Xing, J.; Luo, Q.; Corke, H. Structure-radical scavenging activity relationships of phenolic compounds from traditional Chinese medicinal plants. Life Sci. 2006, 78, 2872-2888.
[2] Zhao, Q.; Chen, X.Y.; Martin, C. Scutellaria baicalensis, the golden herb from the garden of Chinese medicinal plants. Sci. Bull.(Beijing). 2016, 61, 1391-1398.
[3] Shang, X.F.; He, X.R.; He, X.Y.; Li, M.X.; Zhang, R.X.; Fan, P.C.; Zhang, Q.L.; Jia, Z.P. The genus Scutellaria: an ethnopharmacological and phytochemical review. J. Ethnopharmacol. 2010, 128, 279-313.
[4] EghbaliFeriz, S.; Taleghani, A.; Tayarani-Najaran, Z. Scutellaria: Debates on the anticancer property. Biomed. Pharmacother. 2018, 105, 1299-1310.
[5] Li, X.W.; Hedge, I.C. Scutellaria L. Flora China. 1994, 17, 75−103.
[6] Zhang, Y.Y.; Guo, Y.Z.; Ageta, H.; Harigaya, Y.; Onda, M.; Hashimoto, K.; Ikeya, Y.; Okada, M.; Maruno, M. Quantitative analysis of flavonoids in Scutellariae Radix of different sources and seasonal variation by HPLC. J. Chin. Pharm. Sci. 1998, 7, 138-141.
[7] Seo, O.N.; Kim, G.S.; Kim, Y.H.; Park, S.; Jeong, S.W.; Lee, S.J.; Jin, J.S.; Shin, S.C. Determination of polyphenol components of Korean Scutellaria baicalensis Georgi using liquid chromatography-tandem mass spectrometry: contribution to overall antioxidant activity. J. Funct. Foods. 2013, 5, 1741-1750.
[8] Xie, L.H.; Wang, X.; Basnet, P.; Matsunaga, N.; Yamaji, S.; Yang, D.Y.;Cai, S.Q.; Tani, T. Evaluation of variation of acteoside and three major flavonoids in wild and cultivated Scutellaria baicalensis roots by micellar electrokinetic chromatography. Chem. Pharm. Bull. 2002, 50, 896-899.
[9] Chahar, M.K.; Sharma, N.; Dobhal, M.P.; Joshi, Y.C. Flavonoids: A versatile source of anticancer drugs. Pharmacogn. Rev. 2011, 5, 1-12.
[10] Singh, M.; Kaur, M.; Silakari, O. Flavones: An important scaffold for medicinal chemistry. Eur. J. Med. Chem. 2014, 84, 206-239.
[11] Olennikov, D.N.; Chirikova, N.K.; Tankhaeva, L.M. Phenolic compounds of Scutellaria baicalensis Georgi. Russ. J. Bioorg. Chem. 2010, 36, 816-824.
[12] Shen, J.; Li, P.; He, C.N.; Liu, H.T.; Liu, Y.Z.; Sun, X.B.; Xu, R.; Xiao, P.G. Simultaneous determination of 15 flavonoids from different parts of Scutellaria baicalensis and its chemometrics analysis. Chin. Herb. Med. 2018, 11, 20-27.
[13] Horvath, C.R.; Martos, P.A.; Saxena, P.K. Identification and quantification of eight flavones in root and shoot tissues of the medicinal plant huang-qin (Scutellaria baicalensis Georgi) using high-performance liquid chromatography with diode array and mass spectrometric detection. J. Chromatogr. A. 2005, 1062, 199-207.
[14] Takido, M.; Aimi, M.; Takahashi, S.; Yamanouchi, S.; Torii, H. Studies on the constituents in the water extracts of crude drugs. I. On the roots of Scutellaria baicalensis Georgi (Wōgon) (1) (author’s transl). Yakugaku Zasshi. 1975, 95, 108-113.
[15] Takagi, S.; Yamaki, M.; Inoue, K. Studies on the water-soluble constituents of the roots of Scutellaria baicalensis Georgi (Wogon) (1) (author’s transl). Yakugaku Zasshi. 1980, 100, 1220-1224.
[16] Tomimori, T.; Jin, H.; Miyaichi, Y.; Toyofuku, S.; Namba, T. Studies on the constituents of Scutellaria species. VI. On the flavonoid constituents of the root of Scutellaria baicalensis Georgi (5). Quantitative analysis of flavonoids in Scutellaria roots by high-performance liquid chromatography. Yakugaku Zasshi. 1985, 105, 148-155.
[17] Takino, Y.; Miyahara, T.; Arichi, E.; Arichi, S.; Hayashi, T.; Karikura, M. Determination of some flavonoids in scutellariae radix by high-performance liquid chroma-tography. Chem. Pharm. Bull. 1987, 35, 3494-3497.
[18] Li, C.R.; Zhou, L.M.; Zuo, Z. Contents of major bioactive flavones in proprietary traditional Chinese medicine products and reference herb of radix Scutellariae. J. Pharm. Biomed. Anal. 2009, 50, 298-306.
[19] Liu, G.Z.; Ma, J.N.; Chen, Y.Z.; Tian, Q.Q.; Shen, Y.; Wang, X.S.; Chen, B.; Yao, S.Z. Investigation of flavonoid profile of Scutellaria bacalensis Georgi by high performance liquid chromatography with diode array detection and electrospray ion trap mass spectrometry. J. Chromatogr. A. 2009, 1216, 4809-4814.
[20] Ji, S.; Li, R.; Wang, Q.; Miao, W.J.; Li, Z.W.; Si, L.L.; Qiao, X.; Yu, S.W.; Zhou, D.M.; Ye, M. Anti-H1N1 virus, cytotoxic and Nrf2 activation activities of chemical constituents from Scutellaria baicalensis. J. Ethnopharmacol. 2015, 176, 475-484.
[21] Kosakowska, O. Experimental Paper. Intrapopulation variability of flavonoid content in roots of Baikal skullcap (Scutellaria baicalensis Georgi). Herba Pol. 2017, 63, 20-31.
[22] Tomimori, T.; Miyaichi, Y.; Imoto, Y.; Kizu, H.; Tanabe, Y. Studies on the constituents of Scutellaria species. III. On the flavonoid constituents of the root of Scutellaria baicalensis Georgi (3). Yakugaku Zasshi. 1984, 104, 524-528.
[23] Zhang, Y.Y.; Don, H.Y.; Guo, Y.Z.; Ageta, H.; Harigaya, Y.; Onda, M.; Hashimoto, K.; Ikeya, Y.; Okada, M.; Maruno, M. Comparative study of Scutellaria planipes and Scutellaria baicalensis. Biomed. Chromatogr. 1998, 12, 31-33.
[24] Ishimaru, K.; Nishikawa, K.; Omoto, T.; Asai, I.; Yoshihira, K.; Shimomura, K. Two flavone 2’-glucosides from Scutellaria baicalensis. Phytochemistry. 1995, 40, 279-281.
[25] Tomimori, T.; Miyaichi, Y.; Kizu, H. On the flavonoid constituents from the roots of Scutellaria baicalensis Georgi. I. Yakugaku Zasshi. 1982, 102, 388-391.
[26] Takagi, S.; Yamaki, M.; Inoue, K. Flavone di-C-glycosides from Scutellaria baicalensis. Phytochemistry. 1981, 20, 2443-2444.
[27] Tomimori, T.; Miyaichi, Y.; Imoto, Y.; Kizu, H.; Tanabe Y. Studies on the constituents of Scutellaria species. II. On the flavonoid constituents of the root of Scutellaria baicalensis Georgi (2). Yakugaku Zasshi. 1983, 103, 607-611.
[28] Zhang, Y.Y.; Guo, Y.Z.; Onda, M.; Hashimoto, K.; Ikeya, Y.; Okada, M.; Maruno, M. Four flavonoids from Scutellaria baicalensis. Phytochemistry. 1994, 35, 511-514.
[29] Takagi, S.; Yamaki, M.; Inoue, K. On the minor constituents of the roots of Scutellaria baicalensis Georgi (Wogon) (author’s transl). Yakugaku Zasshi. 1981, 101, 899-903.
[30] Tomimori, T.; Miyaichi, Y.; Imoto, Y.; Kizu, H.; Suzuki, C. Studies on the constituents of Scutellaria species. IV. On the flavonoid constituents of the root of Scutellaria baicalensis Georgi (4). Yakugaku Zasshi. 1984, 104, 529-534.
[31] Liu, H.; Dong, Y.H.; Gao, Y.T.; Du, Z.P.; Wang, Y.T.; Cheng, P.; Chen, A.M.; Huang, H. The fascinating effects of baicalein on cancer: A review. Int. J. Mol. Sci. 2016, 17, E1681.
[32] Nurul Islam, M.; Downey, F.; Ng, C.K.Y. Comparative analysis of bioactive phytochemicals from Scutellaria baicalensis, Scutellaria lateriflora, Scutellaria racemosa, Scutellaria tomentosa and Scutellaria wrightii by LC-DAD-MS. Metabolomics. 2011, 7, 446-453.
[33] Li-Weber, M. New therapeutic aspects of flavones: The anticancer properties of Scutellaria and its main active constituents wogonin, baicalein and baicalin. Cancer Treat. Rev. 2009, 35, 57-68.
[34] Gao, Y.; Snyder, S.A.; Smith, J.N.; Chen, Y.C. Anticancer properties of baicalein: A review. Med. Chem. Res. 2016, 25, 1515-1523.
[35] Gong, W.Y.; Zhao, Z.X.; Liu, B.J.; Lu, L.W.; Dong, J.C. Exploring the chemopreventive properties and perspectives of baicalin and its aglycone baicalein in solid tumors. Eur. J. Med. Chem. 2017, 126, 844-852.
[36] Donald, G.; Hertzer, K.; Eibl, G. Baicalein: an intriguing therapeutic phytochemical in pancreatic cancer. Curr. Drug Targets. 2012, 13, 1772-1776.
[37] Yan, W.J.; Ma, X.C.; Gao, X.Y.; Xue, X.H.; Zhang, S.Q. Latest research progress in the correlation between baicalein and breast cancer invasion and metastasis. Mol. Clin. Oncol. 2016, 4, 472-476.
[38] Bie, B.B.; Sun, J.; Guo, Y.; Li, J.; Jiang, W.; Yang, J.; Huang, C.; Li, Z.F. Baicalein: A review of its anti-cancer effects and mechanisms in hepatocellular carcinoma. Biomed. Pharmacother. 2017, 93, 1285-1291.
[39] Ye, F.F.; Wang, H.H.; Zhang, L.S.; Zou, Y.Y.; Han, H.L.; Huang, J. Baicalein induces human osteosarcoma cell line MG-63 apoptosis via ROS-induced BNIP3 expression. Tumour Biol. 2015, 36, 4731-4740.
[40] Tong, W.G.; Ding, X.Z.; Adrian, T.E. The mechanisms of lipoxygenase inhibitor-induced apoptosis in human breast cancer cells. Biochem. Biophys. Res. Commun. 2002, 296, 942-948.
[41] Tong, W.G.; Ding, X.Z.; Witt, R.C.; Adrian, T.E. Lipoxygenase inhibitors attenuate growth of human pancreatic cancer xenografts and induce apoptosis through the mitochondrial pathway. Mol. Cancer Ther. 2002, 1, 929-935.
[42] Bednar, W.; Holzmann, K.; Marian, B. Assessing 12(S)-lipoxygenase inhibitory activity using colorectal cancer cells overexpressing the enzyme. Food Chem. Toxicol. 2007, 45, 508-514.
[43] Zhou, Q.M.; Wang, S.; Zhang, H.; Lu, Y.Y.; Wang, X.F.; Motoo, Y.; Su, S.B. The combination of baicalin and baicalein enhances apoptosis via the ERK/p38 MAPK pathway in human breast cancer cells. Acta Pharmacol. Sin. 2009, 30, 1648-1658.
[44] Zhang, H.B.; Lu, P.; Guo, Q.Y.; Zhang, Z.H.; Meng, X.Y. Baicalein induces apoptosis in esophageal squamous cell carcinoma cells through modulation of the PI3K/Akt pathway. Oncol. Lett. 2013, 5, 722-728.
[45] Guo, Z.X.; Hu, X.L.; Xing, Z.Q.; Xing, R.; Lv, R.; Cheng, X.Y.; Su, J.; Zhou, Z.L.; Xu, Z.H.; Nilsson, S.; Liu, Z.X. Baicalein inhibits prostate cancer cell growth and metastasis via the caveolin-1/AKT/mTOR pathway. Mol. Cell. Biochem. 2015, 406, 111-119.
[46] Pidgeon, G.P.; Kandouz, M.; Meram, A.; Honn, K.V. Mechanisms controlling cell cycle arrest and induction of apoptosis after 12-lipoxygenase inhibition in prostate cancer cells. Cancer Res. 2002, 62, 2721-2727.
[47] Lee, H.Z.; Leung, H.W.; Lai, M.Y.; Wu, C.H. Baicalein induced cell cycle arrest and apoptosis in human lung squamous carcinoma CH27 cells. Anticancer Res. 2005, 25, 959-964.
[48] Cheng, Y.H.; Li, L.A.; Lin, P.P.; Cheng, L.C.; Hung, C.H.; Chang, N.W.; Lin, C. Baicalein induces G1 arrest in oral cancer cells by enhancing the degradation of cyclin D1 and activating AhR to decrease Rb phosphorylation. Toxicol. Appl. Pharmacol. 2012, 263, 360-367.
[49] Wu, B.; Li, J.; Huang, D.M.; Wang, W.W.; Chen, Y.; Liao, Y.X.; Tang, X.W.; Xie, H.F.; Tang, F.Q. Baicalein mediates inhibition of migration and invasiveness of skin carcinoma through Ezrin in A431 cells. BMC Cancer. 2011, 11, 527.
[50] Chen, K.L.; Zhang, S.; Ji, Y.Y.; Li, J.; An, P.; Ren, H.T.; Liang, R.R.; Yang, J.; Li, Z.F. Baicalein inhibits the invasion and metastatic capabilities of hepatocellular carcinoma cells via down-regulation of the ERK pathway. PLoS One. 2013, 8, e72927.
[51] Chai, Y.X.; Xu, J.Z.; Yan, B.J. The anti-metastatic effect of baicalein on colorectal cancer. Oncol. Rep. 2017, 37, 2317-2323.
[52] Zhang, Z.N.; Lv, J.; Lei, X.M.; Li, S.Y.; Zhang, Y.; Meng, L.H.; Xue, R.L.; Li, Z.F. Baicalein reduces the invasion of glioma cells via reducing the activity of p38 signaling pathway. PLoS One. 2014, 9, e90318.
[53] Yan, X.; Rui, X.J.; Zhang K. Baicalein inhibits the invasion of gastric cancer cells by suppressing the activity of the p38 signaling pathway. Oncol. Rep. 2015, 33, 737-743.
[54] Chen, F.L.; Zhuang, M.K.; Peng, J.; Wang, X.Z.; Huang, T.X.; Li, S.M.; Lin, M.Q.; Lin, H.M.; Xu, Y.T.; Li, J.Y.; Chen, Z.X.; Huang, Y.H. Baicalein inhibits migration and invasion of gastric cancer cells through suppression of the TGF-β signaling pathway. Mol. Med. Rep. 2014, 10, 1999-2003.
[55] Shang, D.; Li, Z.; Zhu, Z.; Chen, H.; Zhao, L.; Wang, X.; Chen, Y. Baicalein suppresses 17-β-estradiol-induced migration, adhesion and invasion of breast cancer cells via the G protein-coupled receptor 30 signaling pathway. Oncol. Rep. 2015, 33, 2077-2085.
[56] Wang, L.; Ling, Y.; Chen, Y.; Li, C.L.; Feng, F.; You, Q.D.; Lu, N.; Guo, Q.L. Flavonoid baicalein suppresses adhesion, migration and invasion of MDA-MB-231 human breast cancer cells. Cancer Lett. 2010, 297, 42-48.
[57] Wu, B.; Li, J.; Huang, D.M.; Wang, W.W.; Chen, Y.; Liao, Y.X.; Tang, X.W.; Xie, H.F.; Tang, F.Q. Baicalein mediates inhibition of migration and invasiveness of skin carcinoma through Ezrin in A431 cells. BMC Cancer. 2011, 11, 527.
[58] Park, H.S.; Park, K.I.; Hong, G.E.; Nagappan, A.; Lee, H.J.; Kim, E.H.;Lee, W.S.; Shin, S.C.; Seo, O.N.; Won, C.K.; Cho, J.H.; Kim, G. Korean Scutellaria baicalensis Georgi methanol extracts inhibits metastasis via the Forkhead Box M1 activity in hepatocellular carcinoma cells. J. Ethnopharmacol. 2014, 155, 847-851.
[59] Liu, T.Y.; Gong, W.; Tan, Z.J.; Lu, W.; Wu, X.S.; Weng, H.;Ding, Q.; Shu, Y.J.; Bao, R.F.; Cao, Y.; Wang, X.A. Baicalein inhibits progression of gallbladder cancer cells by down-regulating ZFX. PLoS One. 2015, 10, e0114851.
[60] Gao, X.Y.; Xue, X.H.; Ma, Y.N.; Zhang, S.Q. Effect of baicalein on the expression of SATB1 in human breast cancer cells. Exp. Ther. Med. 2015, 9, 1665-1669.
[61] Ma, X.C.; Yan, W.J.; Dai, Z.J.; Gao, X.Y.; Ma, Y.N.; Xu, Q.T.; Jiang, J.T.; Zhang, S.Q. Baicalein suppresses metastasis of breast cancer cells by inhibiting EMT via downregulation of SATB1 and Wnt/β-catenin pathway. Drug Des. Devel. Ther. 2016, 10, 1419-1441.
[62] Plochmann, K.; Korte, G.; Koutsilieri, E.; Richling, E.; Riederer, P.; Rethwilm, A.;Schreier, P.; Scheller, C. Structure-activity relationships of flavonoid-induced cytotoxicity on human leukemia cells. Arch. Biochem. Biophys. 2007, 460, 1-9.
[63] Touil, Y.S.; Fellous, A.; Scherman, D.; Chabot, G.G. Flavonoid-induced morphological modifications of endothelial cells through microtubule stabilization. Nutr. Cancer. 2009, 61, 310-321.
[64] Huang, S.T.; Lee, Y.; Gullen, E.A.; Cheng, Y.C. Impacts of baicalein analogs with modification of the 6th position of A ring on the activity toward NF-kappaB-, AP-1-, or CREB-mediated transcription. Bioorg. Med. Chem. Lett. 2008, 18, 5046-5049.
[65] Luo, R.; Wang, J.B.; Zhao, L.; Lu, N.; You, Q.D.; Guo, Q.L.; Li, Z.Y. Synthesis and biological evaluation of baicalein derivatives as potent antitumor agents. Bioorg. Med. Chem. Lett. 2014, 24, 1334-1338.
[66] Neves, M.P.; Cidade, H.; Pinto, M.; Silva, A.M.S.; Gales, L.; Damas, A.M.; Lima, R.T.; Vasconcelos, M.H.; de Sao Jose Nascimento, M. ChemInform abstract: prenylated derivatives of baicalein and 3,7-dihydroxyflavone: synthesis and study of their effects on tumor cell lines growth, cell cycle and apoptosis. Eur. J. Med. Chem. 2011, 46, 2562-2574.
[67] Chiu, Y.W.; Lin, T.H.; Huang, W.S.; Teng, C.Y.; Liou, Y.S.; Kuo, W.H.; Lin, W.L.; Huang, H.I.; Tung, J.N.; Huang, C.Y.; Liu, J.Y.; Wang, W.H.; Hwang, J.M.; Kuo, H.C. Baicalein inhibits the migration and invasive properties of human hepatoma cells. Toxicol. Appl. Pharmacol. 2011, 255, 316-326.
[68] Yoshino, M.; Ito, M.; Okajima, H.; Haneda, M.; Murakami, K. Role of baicalein compounds as antioxidant in the traditional herbal medicine. Biomed. Res. 1997, 18, 349-352.
[69] Shieh, D.E.; Liu, L.T.; Lin, C.C. Antioxidant and free radical scavenging effects of baicalein, baicalin and wogonin. Anticancer Res. 2000, 20, 2861-2865.
[70] Zandi, K.; Teoh, B.T.; Sam, S.S.; Wong, P.F.; Mustafa, M.R.; Abubakar, S. Novel antiviral activity of baicalein against dengue virus. BMC Complement. Altern. Med. 2012, 12, 214.
[71] Oo, A.; Teoh, B.T.; Sam, S.S.; Abu Bakar, S.A.; Zandi, K. Baicalein and baicalin as Zika virus inhibitors. Arch. Virol. 2019, 164, 585-593.
[72] Huang, H.L.; Wang, Y.J.; Zhang, Q.Y.; Liu, B.; Wang, F.Y.; Li, J.J.; Zhu, R.Z. Hepatoprotective effects of baicalein against CCl4-induced acute liver injury in mice. World J. Gastroenterol. 2012, 18, 6605-6613.
[73] Huang, Y.; Tsang, S.Y.; X.Q.; Chen, Z.N. Biological properties of baicalein in cardiovascular system. Curr. Drug Targets. 2005, 5, 177-184.
[74] Gao, H.; Kawabata, J. Importance of the B ring and its substitution on the alpha-glucosidase inhibitory activity of baicalein, 5,6,7-trihydroxyflavone. Biosci. Biotechnol. Biochem. 2004, 68, 1858-1864.
[75] Gao, H.; Nishioka, T.; Kawabata, J.; Kasai, T. Structure-activity relationships for α-glucosidase inhibition of baicalein, 5,6,7-trihydroxyflavone: the effect of A-ring substitution. Biosci. Biotechnol. Biochem. 2004, 68, 369-375.
[76] Fu, Y.; Luo, J.; Jia, Z.Q.; Zhen, W.; Zhou, K.Q.; Gilbert, E.; Liu, D.M. Baicalein protects against type 2 diabetes via promoting islet β-cell function in obese diabetic mice. Int. J. Endocrinol. 2014, 2014, 846742.
[77] Oh, M.C.; Piao, M.J.; Fernando, P.M.; Han, X.; Madduma Hewage, S.R.; Park, J.E.;Ko, M.S.; Jung, U.; Kim, I.G.; Hyun, J.W. Baicalein protects human skin cells against ultraviolet B-induced oxidative stress. Biomol. Ther (Seoul). 2016, 24, 616-622.
[78] Ahn, H.C.; Lee, S.Y.; Kim, J.W.; Son, W.S.; Shin, C.G.; Lee, B.J. Binding aspects of baicalein to HIV-1 integrase. Mol. Cells. 2001, 12, 127-130.
[79] Ribeiro, A.R.S.; do Nascimento Valença, J.D.N.; da Silva Santos, J.; Boeing, T.; da Silva, L.M.; de Andrade, S.F.; Albuquerque-Júnior, R.L.C.; Thomazzi, S.M. The effects of baicalein on gastric mucosal ulcerations in mice: Protective pathways and anti-secretory mechanisms. Chemico-Biol. Interact. 2016, 260, 33-41.
[80] Dinda, B.; Dinda, S.; DasSharma, S.; Banik, R.; Chakraborty, A.; Dinda, M. Therapeutic potentials of baicalin and its aglycone, baicalein against inflammatory disorders. Eur. J. Med. Chem. 2017, 131, 68-80.
[81] Chen, Y.; Liu, T.J.; Wang, K.; Hou, C.C.; Cai, S.Q.; Huang, Y.Y.; Du, Z.Y.; Huang, H.; Kong, J.L.; Chen, Y.Q. Baicalein inhibits Staphylococcus aureus biofilm formation and the quorum sensing system in vitro. PLoS One. 2016, 11, e0153468.
[82] Sowndhararajan, K.; Deepa, P.; Kim, M.; Park, S.J.; Kim, S. Baicalein as a potent neuroprotective agent: A review. Biomed. Pharmacother. 2017, 95, 1021-1032. |